Biotech group Biophytis to recruit more patients for COVID-19 treatment trial
- Country:
- France
Biotechnology group Biophytis said it had received regulatory approval in France and Belgium to recruit more patients for a study of Sarconeos as a potential treatment for breathing problems associated with COVID-19.
"We are extremely pleased that Part 2 of the COVA Study has now also been authorized in France and Belgium," Biophytis CEO Stanislas Veillet said in a statement on Wednesday.
Google News